Clinical Trial Update: Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating chemotherapy plus bevacizumab in elderly patients with non-small cell lung cancer. The status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Grupo de Investigación y Divulgación Oncológica | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 2 | Status: UNKNOWN